HomeRX • CVE
add
Biosyent Inc
Previous close
$10.77
Day range
$11.10 - $11.75
Year range
$8.81 - $12.13
Market cap
134.79M CAD
Avg Volume
4.74K
P/E ratio
19.08
Dividend yield
1.70%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 10.98M | 41.96% |
Operating expense | 5.18M | 27.77% |
Net income | 2.32M | 31.16% |
Net profit margin | 21.13 | -7.61% |
Earnings per share | — | — |
EBITDA | 3.26M | 50.64% |
Effective tax rate | 26.50% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.40M | -26.54% |
Total assets | 42.76M | 6.91% |
Total liabilities | 6.75M | 23.99% |
Total equity | 36.01M | — |
Shares outstanding | — | — |
Price to book | 3.38 | — |
Return on assets | 18.76% | — |
Return on capital | 21.90% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 2.32M | 31.16% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1947
Headquarters
Website
